Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

10 April 2006

The presentation and organization of adaptive cytoprotection in the rat stomach,duodenum, and colon.

Stjepan Mise, Ante Tonkic, Valdi Pesutic, Marija Tonkic, Sandro Mise, Vesna Capkun, Lovorka Batelja, Alenka Boban Blagaic, Neven Kokic, Ivan Zoricic, Davor Saifert, Tomislav Anic, Sven Seiwerth, Predrag Sikiric

Med Sci Monit 2006; 12(4): BR146-153 :: ID: 448896

Abstract

Background: Adaptive cytoprotection could be demonstrated in lesion attenuationwithin the whole gastrointestinal tract, in particular sequences, with onset and duration longer thanthe initial short-lasting period (i.e. one hour) defined by Robert in the stomach only. Material/Methods:Adaptive cytoprotection possibly appeared and lesions were attenuated when the stomach, duodenum or colon,in various combinations and sequences, were challenged with initial (mild) and/or final (strong) irritantsover a two-week period. Rats were challenged with the mild or strong irritants 25% or 96% ethanol intragastrically1 ml/rat (stomach) and cysteamine 40 mg or 400 mg/kg subcutaneously (duodenum), or intrarectally (colon).To postulate the prostaglandin relationship known in Robert's cytoprotection and adaptive cytoprotection,indomethacin (1 mg/kg subcutaneously) was given simultaneously with the second challenge. Results: Administeringthe mild and strong irritant protocols within the same part of the gastrointestinal tract, adaptive cytoprotectionpresents in the stomach (1 h to 14 days), duodenum (2 h to 14 days), but not in the colon. With theseprotocols applied to different parts of the gastrointestinal tract, adaptive cytoprotection cross-reactionwas evident in the stomach-duodenum, duodenum-stomach (1 h-14 days and 2 h-14 days), stomach-colon, andduodenum-colon (both 2-24 hours), but not in the colon-stomach or colon-duodenum. This protection wasfully antagonized with indomethacin. Conclusions: As observed for a day and even weeks, stomach-duodenum-colonadaptive cytoprotection is an important new defensive phenomenon.

Keywords: Colon - physiopathology, Adaptation, Physiological, Cysteamine - toxicity, Duodenum - physiopathology, Ethanol - toxicity, Gastric Mucosa - physiopathology, Intestinal Mucosa - physiopathology, Irritants - toxicity, Necrosis, Rats, Wistar

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750